openPR Logo
Press release

Polymer-drug Conjugates Market Evolving Industry Trends and key Insights by 2026 With Major Influential Players Access Pharma, Abeona Therapeutics, Inc., ADAMA India Private Limited, Avadel., GlaxoSmithKline plc. JenKem Technology USA

03-14-2019 05:04 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Polymer-drug Conjugates

Polymer-drug Conjugates

Polymer-drug conjugates are nano-sized drug products currently used for treating cancer and hepatitis. Polymers are now being synthesized to be sensitive to specific enzymes that are apparent in diseased tissue. Conventional polymers are used in polymer-drug conjugates such as cellulose and chitin can be degraded through enzymatic activity and acidity. The drugs remain attached to the polymer and are not activated until the enzymes associated with the diseased tissue are present. This process significantly minimizes damage to healthy tissues.

Download Highly Informative PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2260

Polymer-drug Conjugates Market Driver

New pipeline drugs developed using polymer-drug conjugation are expected to propel growth of the polymer-drug conjugates market. For instance, in march 2016, National Cancer Institute (NCI) started undergoing phase II clinical study for CRLX101, a nanoparticle drug conjugate composed of 20(S)-Camptothecin conjugated to a linear, cyclodextrin-polyethylene glycol-based polymer, for the treatment of metastatic prostate cancer and the trial is expected to complete by March 2020.

Polymer-drug Conjugates Market Restraint

Limited use of polymer-drug conjugates is expected to restrain growth of the polymer-drug conjugates market. For instance, according to an article published in Bioengineering and Translational Medicine 2016, polymer-drug conjugates are formed by covalent linkage between the drug and polymer and not all of the drugs have chemical functional groups for covalent conjugation. Moreover, they offer triggered drug release only at the tumor tissue or cell.

Lack of standard and optimized preclinical or clinical protocols to evaluate polymer-drug conjugate stability, tumor penetration, metabolism, and toxicity are hindering growth of the polymer-drug conjugates market.

Key Comapanies

Key players operating in polymer-drug conjugates market include, Access Pharma, Abeona Therapeutics, Inc., ADAMA India Private Limited, Avadel., GlaxoSmithKline plc. JenKem Technology USA, Lipotek, Sansheng Pharmaceutical Group, Landec Corporation, and Gowan Company.

Polymer-drug Conjugates Market – Regional Analysis

On the basis of region, the global polymer-drug conjugates market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is projected to hold dominant position in the global polymer-drug conjugates market due to increase in number of clinical trials in the U.S. For instance, in January 2018, Apellis Pharmaceuticals announced to conduct phase III clinical study for APL-2 in the U.S. APL-2 is a synthetic cyclic peptide drug conjugated to a polyethylene glycol polymer for the treatment of geographic atrophy associated with age-related macular degeneration.

Place Your Queries For Our Analyst @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2260

Furthermore, increasing research on novel Drug Delivery Systems (DDS) in Asia Pacific is expected to contribute to significant growth of the polymer drug conjugates market in the region during the forecast period. For instance, in August 2018, Osaka University, in collaboration with Tokyo Institute of Technology, Japan, developed a DDS using polyethylene glycol and polylysine block copolymer, with ubenimex conjugate (PEG-b-PLys (Ube). Intravenous injection of ubenimex with these polymers in mice, found to reduce the tumor size significantly. Such results are expected to be a positive traction for growth of the market during the forecast period.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polymer-drug Conjugates Market Evolving Industry Trends and key Insights by 2026 With Major Influential Players Access Pharma, Abeona Therapeutics, Inc., ADAMA India Private Limited, Avadel., GlaxoSmithKline plc. JenKem Technology USA here

News-ID: 1655155 • Views: 676

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Conjugates

Oncology Antibody Drug Conjugates Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027. Pfizer Inc., Astellas Pharma Inc., Gilead Sciences, Inc., GlaxoSmithKline, F. Hoffmann-La Roche AG, Daiichi Sankyo, AstraZeneca, Sanofi, AbbVie, Merck & Co., Byondis, RemeGen, ImmunoGen, Seagen, Rakuten Medical,
Global Antibody Drug Conjugates Market Insights, Forecast
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement
Phycobiliprotein Conjugates Market Perceive Robust Expansion by 2025
Proteins that are present in cyanobacteria and Specific algae like glaucocystophytes, cryptomonads and rhodophytes are called as Phycobiliprotein. These algae that captures the sunlight and passes on to chlorophyll in the course of photosynthesis. Phycobiliproteins are water-soluble proteins. Phycobiliproteins are composed of a proteins and covalently bounded phycobilins that captures light energy. It comprises of the very crucial part if the phycobilisomes. Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/16558 Due to their
Vaccine Conjugates Market 2027: Complete Research Report
Vaccine Conjugates Market Analysis by Indication (Influenza, Pneumococcal, Meningococcal, Others), By Key Companies (GlaxoSmithKline plc.(U.K), Merck & Co., Inc.(U.S), Fablife. (India), SutroVax Inc.(U.S) & others), by Type (Haemophilus B, Monovalent, Multivalent, Others), - Forecast to 2027 Market Synopsis of Vaccine Conjugates Market Scenario: Globally the market for Vaccine Conjugates is increasing rapidly. The factors that influence the growth of Vaccine Conjugates Extending government proposals for vaccinations, mechanical advancements and significant reasons for
2027 Vaccine Conjugates Market Comprehensive Analysis & Worldwide Foresight
Vaccine Conjugates Market Analysis by Indication (Influenza, Pneumococcal, Meningococcal, Others), By Key Companies (GlaxoSmithKline plc.(U.K), Merck & Co., Inc.(U.S), Fablife. (India), SutroVax Inc.(U.S) & others), by Type (Haemophilus B, Monovalent, Multivalent, Others), - Forecast to 2027 Market Synopsis of Vaccine Conjugates Market Scenario: Globally the market for Vaccine Conjugates is increasing rapidly. The factors that influence the growth of Vaccine Conjugates Extending government proposals for vaccinations, mechanical advancements and significant reasons for
Cancer Antibody Drug Conjugates Market Cancer Antibody Drug Conjugates Clinical …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Impetus of Antibody Drug Conjugates 1.1 Prologue to Cancer Antibody Drug Conjugate 1.2 The ABCs of ADCs Structural Entities of Antibody Drug Conjugate 2.1 Rational Design of Antibody Drug Conjugates 2.1.1 Monoclonal Antibody 2.1.2 Linker 2.1.3 Drug Payload 2.2 Aspects of Conjugational Chemistry Revolutionizing Antibody Drug Conjugates Generation